Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October: Cell & Gene Meeting on the Mesa 2019 Corporate presentation Wednesday, Oct 2nd at 3:15 p.m. Pacific Time Location: Carlsbad, CA Panel: What does the future hold for gene editing? Friday, Oct 4th at 9:45 a.m. Pacific Time Location: Carlsbad, CA Cantor Global Hea